Top-Performing Biotech and Drug Stocks During ASCO ’15

Between May 12 and June 3, Oncothyreon’s stock price rose 183%, best among all the companies presenting cancer drug research at the American Society of Clinical Oncology annual meeting.

Source: www.thestreet.com

---